Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia

R McCutcheon, K Beck, E D'Ambrosio… - Acta Psychiatrica …, 2018 - Wiley Online Library
Objective Treatment resistance is a challenge for the management of schizophrenia. It is not
always clear whether inadequate response is secondary to medication ineffectiveness, as …

Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia

J Yang, YH Ko, JW Paik, MS Lee, C Han, SH Joe… - Schizophrenia …, 2012 - Elsevier
OBJECTIVE: The primary aim of this study was to compare electronic monitoring with other
measures of adherence to antipsychotic medication in outpatients with schizophrenia. The …

Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines

DI Velligan, PJ Weiden, M Sajatovic… - Journal of Psychiatric …, 2010 - journals.lww.com
Poor adherence to medication treatment can have devastating consequences for patients
with serious mental illness. The literature review and recommendations in this article …

Strategies to improve medication adherence in patients with schizophrenia: the role of support services

P El-Mallakh, J Findlay - Neuropsychiatric disease and treatment, 2015 - Taylor & Francis
The purpose of this review is to describe research over the past 10 years on the role of
support services in promoting medication adherence in mental health consumers diagnosed …

Are we addressing the 'right stuff'to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication

EM Beck, M Cavelti, S Kvrgic, B Kleim, R Vauth - Schizophrenia research, 2011 - Elsevier
BACKGROUND: Despite the fact that medication adherence is among the most important
health related behaviors in relapse prevention and recovery in schizophrenia, it is often not …

High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of …

J Xiao, W Mi, L Li, Y Shi, H Zhang - Neuropsychiatric disease and …, 2015 - Taylor & Francis
Background Relapse is common in schizophrenia, and seriously impacts patients' quality of
life and social functioning. Many factors have been identified that may potentially increase …

Primary nonadherence to antipsychotic treatment among persons with schizophrenia

J Lieslehto, J Tiihonen, M Lähteenvuo… - Schizophrenia …, 2022 - academic.oup.com
It has remained unclear what factors relate to primary nonadherence to antipsychotic
treatment and whether specific agents and routes of administration differ in how patients …

Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial

S Priebe, K Yeeles, S Bremner, C Lauber, S Eldridge… - Bmj, 2013 - bmj.com
Objective To test whether offering financial incentives to patients with psychotic disorders is
effective in improving adherence to maintenance treatment with antipsychotics. Design …

[HTML][HTML] The importance of suicide risk formulation in schizophrenia

I Berardelli, E Rogante, S Sarubbi, D Erbuto… - Frontiers in …, 2021 - frontiersin.org
Suicide is a cause of early mortality in nearly 5% of patients with schizophrenia, and 25–
50% of patients with schizophrenia attempt suicide in their lifetime. Evidence points to …

[HTML][HTML] Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.

AI Gumley, S Bradstreet, J Ainsworth… - Health Technology …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Relapse is a major determinant of outcome for people with a diagnosis of
schizophrenia. Early warning signs frequently precede relapse. A recent Cochrane Review …